苹果酸脱氢酶2在肿瘤中的作用机制

doi:10.3760/cma.j.issn.1673-422X.2019.03.010

国际肿瘤学杂志 ›› 2019, Vol. 46 ›› Issue (3): 178-180.doi: 10.3760/cma.j.issn.1673-422X.2019.03.010

苹果酸脱氢酶2在肿瘤中的作用机制

吴颖1付白雪1戴璐2黄俊2滕一镔2李琳琳2章静雯2黄玉红1

1大连医科大学基础医学院病理教研室116044； 2大连医科大学临床医学院116044

出版日期:2019-03-08 发布日期:2019-05-17
通讯作者: 黄玉红 E-mail:huangyh_1020@163.com
基金资助:
辽宁省教育厅科学研究项目（L2013356）；教育部留学回国人员科研启动基金（〔2010〕1561）

Functional mechanism of malate dehydrogenase 2 in tumors

Wu Ying1, Fu Baixue1, Dai Lu2, Huang Jun2, Teng Yibin2, Li Linlin2, Zhang Jingwen2, Huang Yuhong1

1Department of Pathology, Basic Medical College of Dalian Medical University, Dalian 116044, China; 2Clinical Medical College of Dalian Medical University, Dalian 116044, China

Online:2019-03-08 Published:2019-05-17
Contact: Huang Yuhong E-mail:huangyh_1020@163.com
Supported by:
Liaoning Provincial Department of Education Scientific Research General Project (L2013356); Research Fund for the Return of Students from the Ministry of Education (〔2010〕1561)

摘要/Abstract

摘要： 苹果酸脱氢酶2（MDH2）在肿瘤中的作用存在双面性，在一些肿瘤中具有促癌作用，而在另一些肿瘤中具有抑制作用。MDH2的功能与能量代谢、肿瘤耐药性及其伪缺氧相互联系。MDH2在肿瘤的发生、发展、侵袭和转移中起重要作用，深入了解MDH2在肿瘤中的作用机制，可为临床提供新的肿瘤干预分子靶点。

关键词: 氧化还原酶类, 肿瘤, 苹果酸脱氢酶2

Abstract: The role of malate dehydrogenase 2 (MDH2) in tumors is doublesided, it has a cancerpromoting effect in some tumors and an inhibitory effect in other tumors. The function of MDH2 is related to energy metabolism, tumor resistance and its pseudo hypoxia. MDH2 plays an important role in the occurrence, development, invasion and metastasis of tumors. An indepth understanding of the functional mechanism of MDH2 in tumors can provide new molecular targets for tumor intervention in the clinic.

Key words: Oxidoreductases, Neoplasms, Malate dehydrogenase 2

吴颖，付白雪，戴璐，黄俊，滕一镔，李琳琳，章静雯，黄玉红. 苹果酸脱氢酶2在肿瘤中的作用机制[J]. 国际肿瘤学杂志, 2019, 46(3): 178-180.

Wu Ying1, Fu Baixue, Dai Lu, Huang Jun, Teng Yibin, Li Linlin, Zhang Jingwen, Huang Yuhong. Functional mechanism of malate dehydrogenase 2 in tumors[J]. Journal of International Oncology, 2019, 46(3): 178-180.

参考文献

［1］ Liu R, Wang H, Liu J, et al. Uncovering the embryonic developmentrelated proteome and metabolome signatures in breast muscle and intramuscular fat of fastand slowgrowing chickens［J］. BMC Genomics, 2017, 18(1): 816. DOI: 10.1186/s1286401741503. ［2］ AitElMkadem S, DayemQuere M, Gusic M, et al. Mutations in MDH2, encoding a Krebs cycle enzyme, cause earlyonset severe encephalopathy［J］. Am J Hum Genet, 2017, 100(1): 151159. DOI: 10.1016/j.ajhg.2016.11.014. ［3］ Oldham WM, Clish CB, Yang Y, et al. Hypoxiamediated increases in L2hydroxyglutarate coordinate the metabolic response to reductive stress［J］. Cell Metab, 2015, 22(2): 291303. DOI: 10.1016/j.cmet.2015.06.021. ［4］ Lo YW, Lin ST, Chang SJ, et al. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicinresistant uterine cancer［J］. J Cell Mol Med, 2015, 19(4): 744759. DOI: 10.1111/jcmm.12388. ［5］ Kim BS, Lee K, Jung HJ, et al. HIF1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1［J］. Biochem Biophys Res Commun, 2015, 458(1): 1420. DOI: 10.1016/j.bbrc.2015.01.031. ［6］ Taniguchi S, Shimatani Y, Fujimori M, et al. Tumortargeting therapy using geneengineered anaerobicnonpathogenic bifidobacterium longum［J］. Methods Mol Biol, 2016, 1409: 4960. DOI: 10.1007/9781493935154_5. ［7］ Zhuang Y, Xiang J, Bao W, et al. MDH2 stimulated by estrogenGPR30 pathway downregulated PTEN expression promoting the proliferation and invasion of cells in endometrial cancer［J］. Transl Oncol, 2017, 10(2): 203210. DOI: 10.1016/j.tranon.2017.01.009. ［8］ Ban HS, Xu X, Jang K, et al. A novel malate dehydrogenase 2 inhibitor suppresses hypoxiainducible factor1 by regulating mitochondrial respiration［J］. PLoS One, 2016, 11(9): e0162568. DOI: 10.1371/journal.pone.0162568. ［9］ Wei J, Yang Y, Lu M, et al. Recent advances in the discovery of HIF1αp300/CBP inhibitors as anticancer agents［J］. Mini Rev Med Chem, 2018, 18(4): 296309. DOI: 10.2174/1389557516666160630124938. ［10］ Lima Queiroz A, Zhang B, Comstock DE, et al. miR1265p targets malate dehydrogenase 1 in nonsmall cell lung carcinomas［J］. Biochem Biophys Res Commun, 2018, 499(2): 314320. DOI: 10.1016/j.bbrc.2018.03.154. ［11］ Latonen L, Afyouniab E, Jylh A, et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression［J］. Nat Commun, 2018, 9(1): 1176. DOI: 10.1038/s41467018035736. ［12］ Cascón A, CominoMéndez I, CurrásFreixes M, et al. Wholeexome sequencing identifies MDH2 as a new familial paragangliomagene［J］. J Natl Cancer Inst, 2015, 107(5): pii: djv053. DOI: 10.1093/jnci/djv053. ［13］ Liu Y, Asnani A, Zou L, et al. Visnagin protects against doxorubicininduced cardiomyopathy through modulation of mitochondrial malate dehydrogenase［J］. Sci Transl Med, 2014, 6(266): 266170. DOI: 10.1126/scitranslmed.3010189. ［14］ Beezhold K, Byersdorfer CA. Targeting immunometabolism to improve anticancer therapies［J］. Cancer Lett, 2018, 414: 127135. DOI: 10.1016/j.canlet.2017.11.005. ［15］ Ylip A, Kivinummi K, Kohvakka A, et al. Transcriptome sequencing reveals PCAT5 as a novel ERGregulated long noncoding RNA in prostate cancer［J］. Cancer Res, 2015, 75(19): 40264031. DOI: 10.1158/00085472.CAN150217. ［16］ Kratochvilova M, Raudenska M, Heger Z, et al. Amino acid profiling of zinc resistant prostate cancer cell lines: associations with cancer progression［J］. Prostate, 2017, 77(6): 604616. DOI: 10.1002/pros.23304. ［17］ Shen H, Hau E, Joshi S, et al. Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism［J］. Mol Cancer Ther, 2015, 14(8): 17941804. DOI: 10.1158/15357163.MCT150247. ［18］ Gentric G, Kieffer Y, Mieulet V, et al. PMLregulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers［J］. Cell Metab, 2019, 29(1): 156173.e10. DOI: 10.1016/j.cmet.2018.09.002. ［19］ Zhang B, Tornmalm J, Widengren J, et al. Characterization of the role of the malate dehydrogenases to lung tumor cell survival［J］. J Cancer, 2017, 8(11): 20882096. DOI: 10.7150/jca.19373. ［20］ Xi L. Visnagin—a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond［J］. Ann Transl Med, 2016, 4(4): 65. DOI: 10.3978/j.issn.23055839.2015.10.43. ［21］ Ippolito L, Marini A, Cavallini L, et al. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells［J］. Oncotarget, 2016, 7(38): 6189061904. DOI: 10.18632/oncotarget.11301. ［22］ Ciccarone F, Vegliante R, Di Leo L, et al. The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer［J］. Semin Cancer Biol, 2017, 47: 5056. DOI: 10.1016/j.semcancer.2017.06.008. ［23］ Jochmanová I, Zhuang Z, Pacak K. Pheochromocytoma: gasping for air［J］. Horm Cancer, 2015, 6(56): 191205. DOI: 10.1007/s1267201502314. ［24］ Chen C, Zhang LG, Liu J, et al. Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data［J］. Onco Targets Ther, 2016, 9: 15451557. DOI: 10.2147/OTT.S98807.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.

苹果酸脱氢酶2在肿瘤中的作用机制

Functional mechanism of malate dehydrogenase 2 in tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价